TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive House Committee Aims To Cut Markup On Office-Administered Cancer Drugs. November 16, 2001
TCL Archive In Brief: Connell Is President of Komen Foundation; Ravikumar Moves to New Jersey Cancer Inst. May 13, 1994
TCL Archive Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL June 11, 2014
